Product Description
FULVESTRANT POWDER is recommended to treat breast cancer. This powder can be stored for 7 to 9 years. It can be used along with ribociclib in case the patient is going through menopause. Available in white powder form, it has 606.77 molar mass. Its solution is used for injection purpose. Its liquid or injection form is viscous and is yellow in color. FULVESTRANT POWDER comprises of inactive ingredients like C2H5OH and castor oil. Its standard has been checked on the basis of its storage life, composition, medicinal attributes, form and possible health hazards.
Pharmacological Purpose and BenefitsFulvestrant Powder is primarily employed as an antineoplastic agent to manage hormone receptor-positive metastatic breast cancer in postmenopausal women. By interfering with estrogen receptors, it helps slow the progression of cancer and can enhance patient outcomes when administered according to medical guidelines.
Packaging, Storage, and Shelf LifeThe powder is meticulously packaged in sealed double PE bags with outer aluminum foil protection to maintain product integrity. For optimum stability, it should be stored in a cool, dry place and protected from light. When stored under recommended conditions, Fulvestrant Powder remains stable for up to two years.
Handling and Safety PrecautionsTo ensure safe use of Fulvestrant Powder, it is important to avoid inhalation and contact with the skin or eyes. Personnel should use appropriate personal protective equipment during handling. The product is intended strictly for pharmaceutical processing and should be administered only under professional supervision.
FAQ's of Fulvestrant Powder:
Q: How should Fulvestrant Powder be stored to ensure its stability?
A: Fulvestrant Powder should be kept in a cool, dry location and protected from light. Ideally, it remains packaged in sealed double PE bags with an outer aluminum foil bag to preserve its quality and extend shelf life up to two years.
Q: What is the principal medical use of Fulvestrant Powder?
A: This powder is used primarily as an antineoplastic agent to treat hormone receptor-positive metastatic breast cancer in postmenopausal women, helping to block estrogen receptor activity and slow tumor growth.
Q: When is Fulvestrant Powder recommended for pharmaceutical applications?
A: Fulvestrant Powder is indicated for use when manufacturing medications intended for hormone receptor-positive metastatic breast cancer in postmenopausal women, as per the prescribed pharmacopoeia standards.
Q: Where can I obtain molecular and structural formula details of Fulvestrant Powder?
A: The molecular formula, C32H47F5O3S, and the molecular weight (606.77 g/mol) are provided, while the detailed structural formula can be supplied upon request from authorized distributors or manufacturers.
Q: What precautions should be taken when handling Fulvestrant Powder?
A: It is essential to avoid inhalation and contact with eyes or skin. Personal protective equipment, such as gloves, masks, and protective clothing, should always be used during handling to minimize health risks.
Q: What are the benefits of using Fulvestrant Powder with USP/EP compliance?
A: Fulvestrant Powder that complies with USP/EP pharmacopoeia standards ensures high purity, consistent quality, and safety, making it suitable for regulated pharmaceutical manufacturing and patient therapies.